You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 27, 2025

Drug Price Trends for NDC 24979-0102


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 24979-0102

Drug NameNDCPrice/Unit ($)UnitDate
BUPROPION HCL XL 300 MG TABLET 24979-0102-02 0.15179 EACH 2025-04-23
BUPROPION HCL XL 300 MG TABLET 24979-0102-06 0.15179 EACH 2025-04-23
BUPROPION HCL XL 300 MG TABLET 24979-0102-07 0.15179 EACH 2025-04-23
BUPROPION HCL XL 300 MG TABLET 24979-0102-02 0.15614 EACH 2025-03-19
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for NDC 24979-0102

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 24979-0102-02 500 140.70 0.28140 2023-06-23 - 2028-06-14 FSS
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 24979-0102-02 500 132.00 0.26400 2023-06-15 - 2028-06-14 FSS
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 24979-0102-02 500 58.77 0.11754 2023-08-04 - 2028-06-14 FSS
BUPROPION HCL 300MG 24HR TAB,SA Golden State Medical Supply, Inc. 24979-0102-02 500 54.43 0.10886 2024-02-21 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for the Drug NDC: 24979-0102

Understanding the National Drug Code (NDC) Directory

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC Directory entails. The FDA's National Drug Code Directory contains comprehensive information on finished drug products, unfinished drugs, and compounded drug products. This directory is updated daily and includes details such as the proprietary name, non-proprietary name, dosage form, route of administration, and marketing dates[1][5].

Identifying the Drug: NDC 24979-0102

Before diving into market analysis and price projections, it is essential to identify the drug associated with the NDC 24979-0102. This involves searching the FDA's NDC Directory using the NDC number to obtain details such as the proprietary name, active ingredients, dosage form, and marketing dates.

Market Trends Affecting Drug Prices

Overall Drug Price Inflation

Vizient projects a 3.81% overall drug price inflation rate for pharmaceuticals in 2025. This inflation is partly driven by the expanding indications of previously approved medications and the introduction of high-cost cell and gene therapies[2][4].

Expanding Indications and New Therapies

The expansion of indications for existing drugs can significantly increase their market value and price. For example, semaglutide has seen a 77% increase in spend since the summer 2023 Outlook due to its expanded indications[4]. If the drug associated with NDC 24979-0102 receives new indications or becomes part of standard care protocols, its price could increase accordingly.

Competition and Generic Alternatives

The presence of generic or biosimilar alternatives can impact the pricing of the drug. If there are no generic alternatives available, the drug may command a premium price. However, if generic versions enter the market, the price of the branded drug could decrease due to increased competition[2].

Specific Market Demand

Condition Incidence and Treatment Algorithms

If the drug identified by NDC 24979-0102 is used to treat a condition with increasing incidence, such as certain types of cancer or chronic diseases, its demand and consequently its price might increase. For instance, in the NSCLC market, drugs like Tagrisso are projected to achieve significant sales growth due to the increasing incorporation of premium-priced immunotherapies into treatment algorithms[2].

Regulatory and Policy Changes

Changes in policy and regulatory landscapes can significantly impact drug pricing. The incoming administration's policy positions on health policies, tariffs, taxes, and M&A oversight could accelerate changes in the pharmaceutical market. For example, changes in reimbursement policies or the introduction of price controls could affect the pricing strategy of pharmaceutical companies[3].

Innovation and Therapeutic Advancements

If the drug identified by NDC 24979-0102 is part of a new class of therapies or has recently received new indications, it may command a premium price. The introduction of high-cost cell and gene therapies is expected to significantly impact provider budgets and operational processes, contributing to the overall drug price inflation[4].

Price Projections

Market Analysis

To accurately project the price of the drug identified by NDC 24979-0102, one must consider the broader market trends, the specific market demand for the drug, competition, regulatory changes, and any new indications or therapeutic advancements.

Example: Impact of Expanding Indications

If the drug receives new indications, its market value could increase significantly. For instance, semaglutide's expansion into new indications has led to a substantial increase in its market value. Similarly, if NDC 24979-0102 sees expanded indications, its price could rise accordingly[2].

Regulatory Impact

Policy changes can significantly influence drug pricing. For example, if there are changes in reimbursement policies or the introduction of price controls, the price of the drug could be affected. Understanding these regulatory changes is crucial for accurate price projections[3].

Key Factors Influencing Price Projections

  • Market Demand: Increasing incidence of the condition treated by the drug.
  • Competition: Presence of generic or biosimilar alternatives.
  • Regulatory Changes: Policy positions on health policies, tariffs, taxes, and M&A oversight.
  • Innovation: New indications or therapeutic advancements.
  • Expanding Indications: New uses for the drug that increase its market value.

Case Study: Similar Drugs

Analyzing the price trends of similar drugs can provide insights into potential price projections for NDC 24979-0102. For example, the price trends for Tadalafil (NDC 24979-0729) show a price per unit of $0.19906 as of January 2025. This data can be used as a benchmark to understand how similar drugs are priced and how their prices might change over time[2].

Conclusion

To accurately project the price of the drug identified by NDC 24979-0102, it is essential to consider a range of factors including market demand, competition, regulatory changes, and innovation. Understanding the broader market trends and the specific data from the NDC Directory is crucial for making informed projections.

Key Takeaways

  • Market Trends: Expanding indications, new therapies, and immunotherapies are driving changes in the pharmaceutical market.
  • Price Inflation: Overall drug price inflation is projected at 3.81% for 2025.
  • Specific Projections: Depend on market demand, competition, regulatory changes, and innovation.
  • Regulatory Impact: Policy changes can significantly influence drug pricing.
  • Market Analysis: Understanding the NDC Directory and specific market data is crucial for accurate price projections.

FAQs

Q: What is the National Drug Code (NDC) Directory? A: The NDC Directory is a database maintained by the FDA that contains information on finished drug products, unfinished drugs, and compounded drug products in the U.S.[1].

Q: How is the NDC Directory updated? A: The NDC Directory is updated daily and includes electronic listing information submitted by labelers[5].

Q: What factors influence drug price projections? A: Factors include market demand, competition, regulatory changes, innovation, and expanding indications[2][3][4].

Q: How does the expansion of indications affect drug prices? A: Expanding indications can significantly increase the market value and price of a drug, as seen with semaglutide[2].

Q: What is the projected overall drug price inflation rate for 2025? A: Vizient projects a 3.81% overall drug price inflation rate for pharmaceuticals in 2025[2].

Sources

  1. FDA's National Drug Code Directory - FDA
  2. Latest drug prices and trends for NDC 24979-0729 - DrugPatentWatch
  3. Pharma industry trends: PwC - PwC
  4. Vizient projects drug price inflation at 3.81% - Vizient, Inc.
  5. NDC Directory (March 2015) - FDA - FDA

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.